Formycon AG announced that it appointed Bernhard Hampl to the Advisory Board. Over the past 20 years, Dr. Bernhard Hampl was CEO in large American generics companies such as EON LABS Inc. and later Sandoz US. He advises companies from the field of pharmaceuticals and biotechnology as well as investment companies.